Blog Community Government Provider 
ABIM
JUNE 20, 2025
ABIM Governance provides a meaningful and rewarding opportunity to join outstanding colleagues in service to the profession and to patients. Read more about how ABIM chooses members of governance. Applications are due Sunday, July 20, 2025. Learn more about what the Council and Specialty Boards do. RN, BSN, PA, NP, Pharm.D.)
Common Sense Family Doctor
JUNE 8, 2025
The organization, which later expanded its list of “gravest threats to health and survival” to include excessive military spending, fossil fuels, and climate change, provides education on the health effects of nuclear testing and reality checks on government messages (eg, duck and cover ) that suggest that nuclear war could be survivable.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
FDA Law Blog
MARCH 6, 2024
FDA Law Blog readers can use discount code S10-866-866L24.S Charles assists clients across a range of FDA-related regulatory matters by providing timely strategic advice on new drug and biologic development and helping them tackle complex regulatory issues. More information about the conference can be found here.
ABIM
APRIL 24, 2025
Visit the ABIM Blog for reports of prior meetings. Expanding ABIM’s engagement with stakeholder communities such as early career physicians, specialty societies and patient-focused organizations. Representatives from the American College of Rheumatology (ACR) joined for a portion of the meeting*. McDonald affirmed as a long-term goal.
FDA Law Blog
APRIL 10, 2025
Food and Drug Administration (FDA) is already having ripple effects not just internally, but across the broader regulatory and life sciences communities and the public at large. Walsh The recent and drastic Reduction In Force (RIF) at the U. FOIA is a U.S.
FDA Law Blog
JANUARY 15, 2024
Koblitz — You know a court decision is going to be worth reading when the judges compare FDA’s regulatory governance of flavored e-cigarettes to a Shakespearean gaslighting. By David B. Clissold & Sara W. FDA said randomized clinical trials could be used, but so could observational studies with respect to cessation data.
FDA Law Blog
JUNE 15, 2022
Kirschenbaum — In 2017, the Centers for Medicare & Medicaid Services (“CMS”) issued a final rule to significantly decrease the rate the government will reimburse 340B hospitals in 2018 for outpatient prescription drugs from average sales price (“ASP”) plus 6% to ASP minus 22.5%. By Faraz Siddiqui & Alan M. 52494 (Nov. Becerra, No.
Expert insights. Personalized for you.
40 
Let's personalize your content